US Senator
Ben Lujan 2025-2026 Regular Session - Authored & Sponsored Legislation
Legislative Session
Primary Sponsor of Legislation
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1004
Introduced
3/12/25
Refer
3/12/25
Pregnant and Postpartum Women Treatment Reauthorization Act
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1022
Introduced
3/13/25
Refer
3/13/25
Strengthening Communities of Recovery Act
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1025
Introduced
3/13/25
Refer
3/13/25
FCC Legal Enforcement Act
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1196
Introduced
3/27/25
Refer
3/27/25
Special Government Employees Transparency Act of 2025
Co-Sponsor of Legislation
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1032
Introduced
3/13/25
Refer
3/13/25
Major Richard Star Act
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1036
Introduced
3/13/25
Refer
3/13/25
Improving Access to Addiction Medicine Providers Act
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1068
Introduced
3/13/25
Refer
3/13/25
Putting Veterans First Act of 2025
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1112
Introduced
3/25/25
Refer
3/25/25
Engrossed
6/23/25
Big Bend National Park Boundary Adjustment Act
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1115
Introduced
3/25/25
Refer
3/25/25
Paycheck Fairness Act
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1132
Introduced
3/26/25
Refer
3/26/25
Families Care Act
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1145
Introduced
3/26/25
Refer
3/26/25
Farmers’ Market Expansion Act of 2025
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1172
Introduced
3/27/25
Refer
3/27/25
Honor Farmer Contracts Act of 2025
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1186
Introduced
3/27/25
Refer
3/27/25
Lower Drug Costs for Families Act This bill applies certain Medicare prescription drug rebate requirements to prescription drugs that are available under private health insurance. Current law requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for brand-name drugs without generic equivalents under Medicare that (1) cost $100 or more per year per individual, and (2) for which prices increase faster than inflation. Manufacturers that fail to comply are subject to civil penalties. The bill applies these requirements to prescription drugs that are available in the commercial market under private health insurance. It also indexes rebate calculations to drug prices in 2016 (as opposed to 2021).
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1193
Introduced
3/27/25
Refer
3/27/25
America’s Red Rock Wilderness Act
US
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1203
Introduced
3/31/25
Refer
3/31/25
Housing Vouchers Fairness Act